- Home
- CMMB vs ONMD Comparison
CMMB vs ONMD Comparison
Compare CMMB & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- ONMD
- Stock Information
- Founded
- CMMB 2004
- ONMD 2006
- Country
- CMMB Israel
- ONMD United States
- Employees
- CMMB N/A
- ONMD N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- ONMD
- Sector
- CMMB Health Care
- ONMD
- Exchange
- CMMB Nasdaq
- ONMD Nasdaq
- Market Cap
- CMMB 22.0M
- ONMD 22.2M
- IPO Year
- CMMB N/A
- ONMD N/A
- Fundamental
- Price
- CMMB $3.02
- ONMD $0.90
- Analyst Decision
- CMMB Strong Buy
- ONMD
- Analyst Count
- CMMB 2
- ONMD 0
- Target Price
- CMMB $26.50
- ONMD N/A
- AVG Volume (30 Days)
- CMMB 108.4K
- ONMD 18.9M
- Earning Date
- CMMB 08-14-2025
- ONMD 08-13-2025
- Dividend Yield
- CMMB N/A
- ONMD N/A
- EPS Growth
- CMMB N/A
- ONMD N/A
- EPS
- CMMB N/A
- ONMD N/A
- Revenue
- CMMB N/A
- ONMD $459,000.00
- Revenue This Year
- CMMB N/A
- ONMD N/A
- Revenue Next Year
- CMMB N/A
- ONMD N/A
- P/E Ratio
- CMMB N/A
- ONMD N/A
- Revenue Growth
- CMMB N/A
- ONMD N/A
- 52 Week Low
- CMMB $3.02
- ONMD $0.30
- 52 Week High
- CMMB $10.20
- ONMD $1.56
- Technical
- Relative Strength Index (RSI)
- CMMB 19.63
- ONMD 63.24
- Support Level
- CMMB $3.32
- ONMD $0.62
- Resistance Level
- CMMB $3.86
- ONMD $0.83
- Average True Range (ATR)
- CMMB 0.28
- ONMD 0.17
- MACD
- CMMB -0.03
- ONMD 0.02
- Stochastic Oscillator
- CMMB 2.65
- ONMD 57.63
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.